LARIMAR THERAPEUTICS INC (LRMR) Stock Cash Flow
NASDAQ:LRMR - US5171251003 - Common Stock
3.94 USD
+0.07 (+1.81%)
3.9955 USD
+0.06 (+1.41%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -99.79M | -80.60M | -36.95M | -35.35M | -50.64M | |||
| Depreciation Amortization | 326.00K | 318.00K | 311.00K | 318.00K | 326.00K | |||
| Change In Working Capital | 3.26M | 5.99M | -2.59M | 1.62M | 2.75M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 3.92M | 3.54M | 5.77M | 5.84M | 5.46M | |||
| OPERATING CASH FLOW | -92.28M | -70.76M | -33.46M | -27.57M | -42.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -309.00K | -515.00K | -164.00K | -100.00K | -333.00K | |||
| Other Investing Activity | 80.07M | -84.87M | 33.52M | -90.86M | 24.50M | |||
| INVESTING CASH FLOW | 79.76M | -85.39M | 33.35M | -90.96M | 24.17M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 161.88M | 30.00K | 75.26M | 19.89M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 66.00K | 161.88M | 30.00K | 75.26M | 19.89M | |||
| CHANGE IN CASH | -12.46M | 5.74M | -76.00K | -43.27M | 1.95M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -92.28M | -70.76M | -33.46M | -27.57M | -42.10M | |||
| Capital Expenditure | -309.00K | -515.00K | -164.00K | -100.00K | -333.00K | |||
| FREE CASH FLOW | -92.59M | -71.28M | -33.62M | -27.67M | -42.44M | |||
All data in USD